High-Risk Prostate Cancer Treatment - MUSC Hollings
David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at MUSC Hollings Cancer Center in Charleston, SC. In this informative video he shares educational information for patients on high-risk prostate cancer treatment.
▶︎
Intermediate Risk Prostate Cancer
▶︎
Robotic Prostate Surgery Recovery: What to Expect
▶︎
Low-Risk Prostate Cancer Treatment - MUSC Hollings
▶︎
Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings
▶︎
How I Live with Stage 4 Metastatic Prostate Cancer | Mark's Story | The Patient Story
▶︎
Risk Assessment of PSA Recurrent Prostate Cancer
▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎
What to do if your PSA test is abnormal | Peter Attia & Ted Schaeffer
▶︎
Many Men Chose The Wrong Prostate Cancer Treatment: Here’s Why
▶︎
Stereotactic Body Radiotherapy for Prostate Cancer | Amar Kishan, MD | UCLAMDChat
▶︎
Gleason Score 8 vs Lower Scores | What's The Real Difference?
▶︎
The ABCs of Androgen Deprivation Therapy
▶︎
Making Decisions After Being Diagnosed with Early Stage Prostate Cancer | UCLAMDChat
▶︎
Prostate Cancer: What You NEED To Know
▶︎
Managing Prostate Cancer Recurrence After Radical Prostatectomy with Dr. Adam S. Kibel, MD
▶︎
Prostate Artery Embolization for Enlarged Prostate: Dr. Sandeep Bagla Explains This BPH Treatment
▶︎
Prostate cancer: State-of-the-art diagnosis and non-invasive treatment
▶︎
Gleason 3+4 Prostate Cancer
▶︎
SBRT & CyberKnife: Who Can Skip ADT/Lupron in Prostate Cancer? with Dr. Jonathan Haas | EP 134
▶︎